Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 25:3:88.
doi: 10.3389/fneur.2012.00088. eCollection 2012.

Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management

Affiliations

Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management

Joana Meireles et al. Front Neurol. .

Abstract

Parkinson's disease (PD) is a common, disabling, neurodegenerative disorder. In addition to classical motor symptoms, non-motor features are now widely accepted as part of the clinical picture, and cognitive decline is a very important aspect of the disease, as it brings an additional significant burden for the patient and caregivers. The diagnosis of cognitive decline in PD, namely mild cognitive impairment (MCI) and dementia, can be extremely challenging, remaining largely based on clinical and cognitive assessments. Diagnostic criteria and methods for PD dementia and MCI have been recently issued by expert work groups. This manuscript has synthesized relevant data in order to obtain a pragmatic and updated review regarding cognitive decline in PD, from milder stages to dementia. This text will summarize clinical features, diagnostic methodology, and therapeutic issues of clinical decline in PD. Relevant clinical genetic issues, including recent advances, will also be approached.

Keywords: Parkinson’s disease; Parkinson’s disease dementia; cognition; dementia; diagnosis; diagnostic criteria; mild cognitive impairment; non-motor symptoms.

PubMed Disclaimer

Figures

Figure 1
Figure 1
schematic representation of the progression of PD patients until the stage of dementia. Functional impairment in PD is multifactorial (motor symptoms, cognitive decline, other non-motor symptoms). Please note that this graph is merely pictorial; it is not intended to represent proportions between variables nor is the progression linear, despite the drawing.

References

    1. Aarsland D., Andersen K., Larsen J. P., Perry R., Wentzel-Larsen T., Lolk A., Kragh-Sørensen P. (2004). The rate of cognitive decline in Parkinson disease. Arch. Neurol. 61, 1906–1911 10.1001/archneur.61.12.1906 - DOI - PubMed
    1. Aarsland D., Ballard C., Larsen J. P., McKeith I. (2001a). A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia. Int. J. Geriatr. Psychiatry 16, 528–536 10.1002/gps.389 - DOI - PubMed
    1. Aarsland D., Cummings J. L., Larsen J. P. (2001b). Neuropsychiatric differences between Parkinson’s disease with dementia and Alzheimer’s disease. Int. J. Geriatr. Psychiatry 16, 184–191 10.1002/gps.389 - DOI - PubMed
    1. Aarsland D., Litvan I., Larsen J. P. (2001c). Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson’s disease. J. Neuropsychiatry Clin. Neurosci. 13, 42–49 10.1176/appi.neuropsych.13.3.374 - DOI - PubMed
    1. Aarsland D., Ballard C., Walker Z., Bostrom F., Alves G., Kossakowski K., Leroi I., Pozo-Rodriguez F., Minthon L., Londos E. (2009). Memantine in patients with Parkinson’s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 8, 613–618 10.1016/S1474-4422(09)70146-2 - DOI - PubMed

LinkOut - more resources